1. Home
  2. HBIO vs UCL Comparison

HBIO vs UCL Comparison

Compare HBIO & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$7.93

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

HOLD

Current Price

$0.38

Market Cap

27.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
UCL
Founded
1901
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Telecommunications Equipment
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
27.8M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
HBIO
UCL
Price
$7.93
$0.38
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
19.3K
1.3M
Earning Date
05-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,176,000.00
N/A
Revenue This Year
$4.77
$11.60
Revenue Next Year
$8.55
N/A
P/E Ratio
N/A
$13.72
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.34
52 Week High
$7.90
$3.58

Technical Indicators

Market Signals
Indicator
HBIO
UCL
Relative Strength Index (RSI) 78.01 25.48
Support Level $5.91 N/A
Resistance Level N/A $0.99
Average True Range (ATR) 0.32 0.07
MACD 0.12 -0.02
Stochastic Oscillator 100.00 4.59

Price Performance

Historical Comparison
HBIO
UCL

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.

Share on Social Networks: